Therapies and Diagnostics for Ovarian Cancer Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Therapies and Diagnostics for Ovarian Cancer Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Report Description

Global Therapies and Diagnostics for Ovarian Cancer Market is expected to grow at CAGR of 7.2% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Therapies and Diagnostics for Ovarian Cancer Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:

KEY PLAYERS

ABBVIE INC.

ASTRA ZENECA

BRISTOL-MYERS SQUIBB

CELGENE CORP.

CLOVIS ONCOLOGY

ELI LILLY AND COMPANY

GLAXOSMITHKLINE PLC

HIKMA PHARMACEUTICALS PLC

JANSSEN PHARMACEUTICALS, INC.

MERCK & CO., INC.

MYRIAD GENETICS INC.

NOVARTIS AG

PFIZER INC.

QUEST DIAGNOSTICS INC.

ROCHE HOLDING AG

TESARO, INC.

Scope of the Market

Diagnosis Market

Cancer Type Market

Epithelial Ovarian Tumors

Germ Cell Tumors

Stromal Tumors

Primary Peritoneal Cancer

Stages of Ovarian Cancer

Prognosis

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW)

Back to top

Payment Options

Single User : $3897 $2,923
Five User: $5175
$3,881
Enterprise : $9175 $6,881